4218 Stock Overview
Develops, manufactures, and sells medical products and tapes in Asia and Europe.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 4218 from our risk checks.
Nichiban Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,777.00 |
52 Week High | JP¥2,128.00 |
52 Week Low | JP¥1,680.00 |
Beta | 0.33 |
11 Month Change | -5.33% |
3 Month Change | -4.36% |
1 Year Change | -8.64% |
33 Year Change | 1.43% |
5 Year Change | 15.17% |
Change since IPO | 30.66% |
Recent News & Updates
Recent updates
Shareholder Returns
4218 | JP Commercial Services | JP Market | |
---|---|---|---|
7D | -6.3% | -14.1% | -18.6% |
1Y | -8.6% | -5.0% | -3.7% |
Return vs Industry: 4218 underperformed the JP Commercial Services industry which returned -5% over the past year.
Return vs Market: 4218 underperformed the JP Market which returned -3.7% over the past year.
Price Volatility
4218 volatility | |
---|---|
4218 Average Weekly Movement | 3.2% |
Commercial Services Industry Average Movement | 4.9% |
Market Average Movement | 5.6% |
10% most volatile stocks in JP Market | 9.0% |
10% least volatile stocks in JP Market | 3.0% |
Stable Share Price: 4218 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4218's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1918 | 1,270 | Toshiaki Takatsu | www.nichiban.co.jp |
Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, and hemostatic and first-aid bandages; and sports tapes, underwraps, scissors, and bags. The company also provides curative drug for corns, calluses, and warts; Navel Compression pack, which is used for umbilical hernia compression treatment in infants; and fabric plasters, permeable film and puncture site protection dressings, absorbent hemostatic pressure dressings, and non-woven surgical tapes.
Nichiban Co., Ltd. Fundamentals Summary
4218 fundamental statistics | |
---|---|
Market cap | JP¥34.78b |
Earnings (TTM) | JP¥1.83b |
Revenue (TTM) | JP¥46.86b |
19.8x
P/E Ratio0.8x
P/S RatioIs 4218 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4218 income statement (TTM) | |
---|---|
Revenue | JP¥46.86b |
Cost of Revenue | JP¥32.99b |
Gross Profit | JP¥13.87b |
Other Expenses | JP¥12.04b |
Earnings | JP¥1.83b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 08, 2024
Earnings per share (EPS) | 89.77 |
Gross Margin | 29.60% |
Net Profit Margin | 3.90% |
Debt/Equity Ratio | 6.3% |
How did 4218 perform over the long term?
See historical performance and comparison